Genus (GENSF) YoY EBITDA Growth : -53.91% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Genus YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Genus's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -53.91%.

Genus's EBITDA per Share for the six months ended in Jun. 2024 was $0.48.

Genus YoY EBITDA Growth Historical Data

The historical data trend for Genus's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus YoY EBITDA Growth Chart

Genus Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY EBITDA Growth

Get a 7-Day Free Trial

108.78

20.66

-14.38

6.65

-23.86

Genus Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															10.34	-11.93	14.11	17.31	-53.91

Genus YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Genus's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (A: Jun. 2024 )
=	(EBITDA per Share (A: Jun. 2024 )	-	EBITDA per Share (A: Jun. 2023 ))	/	\| EBITDA per Share (A: Jun. 2023 ) \|
=	(1.417	-	1.861)	/	\| 1.861 \|
=	-23.86 %

Genus's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(0.477	-	1.035)	/	\| 1.035 \|
=	-53.91 %

Genus YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Genus's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (OTCPK:GENSF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

GNSl:UK GNS:UK GBE:Germany

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.